Glaxosmithkline Pharmaceuticals Ltd.

₹3020.9

Glaxosmithkline Pharmaceuticals Ltd.

₹3020.9

₹3020.9

2.2 (0.07%) - 24 May 2025 02:30 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 51,176 Cr.
52 Week - High/Low ₹ 3,148/1,921
P/E Ratio 55.68
P/B Ratio 28.69
Enterprise Value ₹ -954 Cr.
ROE % 32.96
RSI Value 61.63
EMA 50 2774.2
EMA 200 2539.16
Market Cap. ₹ 51,176 Cr.
52 Week - High/Low ₹ 3,148/1,921
P/E Ratio 55.18
P/B Ratio 28.79
Enterprise Value ₹ -955 Cr.
ROE % 33.43
RSI Value 61.63
EMA 50 2774.2
EMA 200 2539.16

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.